Elif Afacan, Yusuf C. Edek, Nilsel Ilter, Ayla Gülekon

A wide range of dermatological manifestations following different types of SARS-CoV-2 vaccines have been reported in the literature since the beginning of implementation of mass immunization programs. Here we report a case series of seven patients with bullous pemphigoid (BP), four of which had a new-onset BP following vaccination and three had a post-vaccine exacerbation of a previous BP.